{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:33:15Z","timestamp":1790451195458,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neurol.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:43:21Z","timestamp":1762962201000},"page":"821-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tracing Neurological Diseases in the presymptomatic phase: moving forward a detection panel"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-9854","authenticated-orcid":false,"given":"M.","family":"Rival","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Thouvenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2025.08.004_bib0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2025.08.004_bib0130","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","article-title":"Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onset","volume":"15","author":"H\u00e4llqvist","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurol.2025.08.004_bib0135","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1474-4422(23)00281-8","article-title":"Radiologically isolated syndrome","volume":"22","author":"Lebrun-Frenay","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0140","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.08.004_bib0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41582-024-00961-z","article-title":"The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology","volume":"20","author":"Benatar","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0150","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0155","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/alz.12751","article-title":"An accurate fully automated panel of plasma biomarkers for Alzheimer's disease","volume":"19","author":"Palmqvist","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.08.004_bib0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 Revision of McDonald criteria","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jnnp-2022-330796","article-title":"Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis","volume":"94","author":"Leppert","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.08.004_bib0175","doi-asserted-by":"crossref","first-page":"866092","DOI":"10.3389\/fimmu.2022.866092","article-title":"Biological markers in early multiple sclerosis: the paved way for radiologically isolated syndrome","volume":"13","author":"Rival","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/1352458506070264","article-title":"Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis","volume":"13","author":"Callander","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2025.08.004_bib0185","doi-asserted-by":"crossref","first-page":"e200044","DOI":"10.1212\/NXI.0000000000200044","article-title":"Neurofilament light chain levels are predictive of clinical conversion in radiologically isolated syndrome","volume":"10","author":"Rival","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2025.08.004_bib0190","doi-asserted-by":"crossref","first-page":"e200156","DOI":"10.1212\/NXI.0000000000200156","article-title":"Kappa free light chain index predicts disease course in clinically and radiologically isolated syndromes","volume":"10","author":"Levraut","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2025.08.004_bib0195","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40263-024-01117-9","article-title":"Early disease-modifying treatments for presymptomatic multiple sclerosis","volume":"38","author":"Zeydan","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurol.2025.08.004_bib0200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2025.08.004_bib0205","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41467-023-42682-9","article-title":"Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis","volume":"14","author":"\u00c5kesson","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurol.2025.08.004_bib0210","doi-asserted-by":"crossref","first-page":"e200230","DOI":"10.1212\/NXI.0000000000200230","article-title":"CD138 as a specific CSF biomarker of multiple sclerosis","volume":"11","author":"Hinsinger","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2025.08.004_bib0215","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/alz.12907","article-title":"Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: a multi-cohort study","volume":"19","author":"Salvad\u00f3","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.08.004_bib0220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","article-title":"Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study","volume":"21","author":"Morenas-Rodr\u00edguez","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0225","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s43587-025-00835-z","article-title":"Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials","volume":"5","author":"Ossenkoppele","year":"2025","journal-title":"Nat Aging"},{"key":"10.1016\/j.neurol.2025.08.004_bib0230","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u00a0\u2014\u00a0towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.08.004_bib0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","article-title":"The DIAN-TU Next Generation Alzheimer's prevention trial: adaptive design and disease progression model","volume":"13","author":"Bateman","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.08.004_bib0240","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat Aging"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872500606X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872500606X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:38:10Z","timestamp":1763177890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537872500606X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S003537872500606X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.08.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tracing Neurological Diseases in the presymptomatic phase: moving forward a detection panel","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}